These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction of circulating cell-derived and plasma growth factors in stimulating cultured smooth muscle cell replication. Clemmons DR J Cell Physiol; 1984 Nov; 121(2):425-30. PubMed ID: 6386833 [TBL] [Abstract][Full Text] [Related]
3. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells. Cohick WS; Gockerman A; Clemmons DR J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: the role of contaminant platelet-derived growth factor. Libby P; Raines EW; Cullinane PM; Ross R J Cell Physiol; 1985 Dec; 125(3):357-66. PubMed ID: 2415538 [TBL] [Abstract][Full Text] [Related]
5. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor. Yamamoto M; Yamamoto K Exp Cell Res; 1994 May; 212(1):62-8. PubMed ID: 8174643 [TBL] [Abstract][Full Text] [Related]
6. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. Chen JK; Hoshi H; McClure DB; McKeehan WL J Cell Physiol; 1986 Nov; 129(2):207-14. PubMed ID: 3533960 [TBL] [Abstract][Full Text] [Related]
7. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells. Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380 [TBL] [Abstract][Full Text] [Related]
8. Factors involved in supporting the growth and steroidogenic functions of bovine adrenal cortical cells maintained on extracellular matrix and exposed to a serum-free medium. Ill CR; Gospodarowicz D J Cell Physiol; 1982 Dec; 113(3):373-84. PubMed ID: 6294125 [TBL] [Abstract][Full Text] [Related]
9. The role of protein breakdown in growth, quiescence, and starvation of vascular smooth muscle cells. Libby P; O'Brien KV J Cell Physiol; 1984 Mar; 118(3):317-23. PubMed ID: 6365933 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidyl choline and the growth in serum-free medium of vascular endothelial and smooth muscle cells, and corneal endothelial cells. Fujii DK; Cheng J; Gospodarowicz D J Cell Physiol; 1983 Mar; 114(3):267-78. PubMed ID: 6833402 [TBL] [Abstract][Full Text] [Related]
11. A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. Clemmons DR; Gardner LI J Cell Physiol; 1990 Oct; 145(1):129-35. PubMed ID: 1698793 [TBL] [Abstract][Full Text] [Related]
12. Factors involved in the control of proliferation of bovine corneal endothelial cells maintained in serum-free medium. Giguère L; Cheng J; Gospodarowicz D J Cell Physiol; 1982 Jan; 110(1):72-80. PubMed ID: 6461663 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor. Keyes LE; Moore LG; Walchak SJ; Dempsey EC J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771 [TBL] [Abstract][Full Text] [Related]
14. Thrombin induces production of growth factors from aortic smooth muscle cells. Cucina A; Borrelli V; Di Carlo A; Pagliei S; Corvino V; Santoro-D'Angelo L; Cavallaro A; Sterpetti AV J Surg Res; 1999 Mar; 82(1):61-6. PubMed ID: 10068527 [TBL] [Abstract][Full Text] [Related]
15. Effect of HDL on the interaction of hyperlipemic LDL with monkey smooth muscle cells. Bates SR Artery; 1980; 7(4):303-15. PubMed ID: 7213019 [TBL] [Abstract][Full Text] [Related]
16. Effect of rous sarcoma virus transformation of rat-1 fibroblasts upon their growth factor and anchorage requirements in serum-free medium. Giguère L; Gospodarowicz D Cancer Res; 1983 May; 43(5):2121-30. PubMed ID: 6299541 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716. Major TC; Keiser JA J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349 [TBL] [Abstract][Full Text] [Related]
18. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. Scott CD; Weiss J J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917 [TBL] [Abstract][Full Text] [Related]
19. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. Aoyagi M; Fukai N; Sakamoto H; Shinkai T; Matsushima Y; Yamamoto M; Yamamoto K J Cell Physiol; 1991 May; 147(2):191-8. PubMed ID: 2040653 [TBL] [Abstract][Full Text] [Related]
20. PDGF-like growth factor from SV40-transformed smooth muscle cells promotes growth in an autocrine or paracrine manner. Sakata N; Fujimitsu K; Jimi S; Takebayashi S Exp Mol Pathol; 1994 Feb; 60(1):39-51. PubMed ID: 8162969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]